Takeda Y - Search Results

1

Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism.

Sakaguchi S, Okamoto R, Inoue C, Akao M, Kamemura K, Kurihara I, Takeda Y, Ohno Y, Inagaki N, Rakugi H, Katabami T, Tsuiki M, Tanabe A, Tamura K, Fujita S, Yano Y, Dohi K; JRAS investigators; Naruse M. Sakaguchi S, et al. Among authors: takeda y. J Hum Hypertens. 2023 Sep;37(9):757-766. doi: 10.1038/s41371-022-00753-2. Epub 2022 Sep 24. J Hum Hypertens. 2023. PMID: 36153382

2

Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus.

Demura M, Takeda Y, Yoneda T, Furukawa K, Usukura M, Itoh Y, Mabuchi H. Demura M, et al. Among authors: takeda y. Hum Mutat. 2002 Jan;19(1):23-9. doi: 10.1002/humu.10011. Hum Mutat. 2002. PMID: 11754100

3

Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.

Takeda Y, Yoneda T, Demura M, Usukura M, Mabuchi H. Takeda Y, et al. Circulation. 2002 Feb 12;105(6):677-9. doi: 10.1161/hc0602.104675. Circulation. 2002. PMID: 11839620

4

19-Noraldosterone in pregnancy-induced hypertension.

Takeda Y, Yoneda T, Demura M, Furukawa K, Usukura M, Mabuchi H. Takeda Y, et al. Steroids. 2002 Jun;67(7):605-10. doi: 10.1016/s0039-128x(02)00009-0. Steroids. 2002. PMID: 11996933

5

Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism.

Oda N, Takeda Y, Zhu A, Usukura M, Yoneda T, Takata H, Mabuchi H. Oda N, et al. Among authors: takeda y. Hypertens Res. 2006 Jan;29(1):9-14. doi: 10.1291/hypres.29.9. Hypertens Res. 2006. PMID: 16715648

6

Medical treatment of benign insulinoma using octreotide LAR: a case report.

Usukura M, Yoneda T, Oda N, Yamamoto Y, Takata H, Hasatani K, Takeda Y. Usukura M, et al. Among authors: takeda y. Endocr J. 2007 Feb;54(1):95-101. doi: 10.1507/endocrj.k05-157. Epub 2006 Nov 24. Endocr J. 2007. PMID: 17124362 Free article.

7

Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.

Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M. Takeda Y, et al. Am J Hypertens. 2007 Oct;20(10):1119-24. doi: 10.1016/j.amjhyper.2007.05.008. Am J Hypertens. 2007. PMID: 17903697

8

Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus.

Yoneda T, Takeda Y, Usukura M, Oda N, Takata H, Yamamoto Y, Karashima S, Yamagishi M. Yoneda T, et al. Among authors: takeda y. Am J Hypertens. 2007 Dec;20(12):1329-33. doi: 10.1016/j.amjhyper.2007.09.001. Am J Hypertens. 2007. PMID: 18047925 Clinical Trial.

9

Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats.

Zhu A, Yoneda T, Demura M, Karashima S, Usukura M, Yamagishi M, Takeda Y. Zhu A, et al. Among authors: takeda y. J Hypertens. 2009 Apr;27(4):800-5. doi: 10.1097/HJH.0b013e328325d861. J Hypertens. 2009. PMID: 19516179

10

Effects of a high-salt diet on adipocyte glucocorticoid receptor and 11-beta hydroxysteroid dehydrogenase 1 in salt-sensitive hypertensive rats.

Usukura M, Zhu A, Yoneda T, Karashima S, Yagi K, Yamagishi M, Takeda Y. Usukura M, et al. Among authors: takeda y. Steroids. 2009 Nov;74(12):978-82. doi: 10.1016/j.steroids.2009.07.006. Epub 2009 Jul 29. Steroids. 2009. PMID: 19646461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,547 results

Search Page